Form 4: Eli Lilly Director Acquires Shares Through Deferral Plan

Mary Lynne Hedley, a director at Eli Lilly, acquired 11 shares of common stock through a deferral plan, with the shares to be settled after her separation from service.

Summary

• Mary Lynne Hedley, a director at Eli Lilly & Co, has reported a transaction involving the acquisition of 11 shares of common stock.
• The shares were acquired on September 16, 2024, at a price of $923.54 per share.
• These shares were acquired through the Lilly Directors' Deferral Plan, in lieu of cash compensation.
• The shares will be settled in common stock following Ms. Hedley's separation from service.
• Ms. Hedley also has indirect ownership of 1,537 shares held by a trust.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed positively as it aligns director interests with shareholders. There is no indication of any negative sentiment.

Positives

• The acquisition of shares by a director demonstrates confidence in the company's future performance.

Future Outlook

The acquired shares will be settled in common stock following the reporting person's separation from service.

Industry Context

This is a routine filing related to director compensation and is common practice for publicly traded companies.

Comparison to Industry Standards

• Director share acquisitions through deferral plans are a common practice among publicly traded companies, particularly in the pharmaceutical industry.
• Many companies offer similar deferral plans to align director interests with shareholder value.
• The specific terms of the deferral plan, such as the timing of settlement, are typical for these types of arrangements.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns director interests with the company's performance.

Key Dates

Keywords

Eli Lilly, Director, Share Acquisition, Deferral Plan, Stock Units, Common Stock, Beneficial Ownership